SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-18-240959
Filing Date
2018-08-07
Accepted
2018-08-07 15:27:08
Documents
47
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d648701d10q.htm 10-Q 701325
2 EX-31.1 d648701dex311.htm EX-31.1 9711
3 EX-31.2 d648701dex312.htm EX-31.2 9706
4 EX-32.1 d648701dex321.htm EX-32.1 6275
  Complete submission text file 0001193125-18-240959.txt   3034746

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT vrca-20180630.xml EX-101.INS 382126
6 XBRL TAXONOMY EXTENSION SCHEMA vrca-20180630.xsd EX-101.SCH 33455
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vrca-20180630_cal.xml EX-101.CAL 30593
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vrca-20180630_def.xml EX-101.DEF 183321
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE vrca-20180630_lab.xml EX-101.LAB 293987
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vrca-20180630_pre.xml EX-101.PRE 239367
Mailing Address 200 GARRETT STREET CHARLOTTESVILLE VA 22902
Business Address 200 GARRETT STREET CHARLOTTESVILLE VA 22902 434-980-8100
Verrica Pharmaceuticals Inc. (Filer) CIK: 0001660334 (see all company filings)

IRS No.: 463137900 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38529 | Film No.: 18997712
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences